Drug Shortage Report for AURO-SILODOSIN

Last updated on 2023-09-14 History
Report ID 166769
Drug Identification Number 02478501
Brand name AURO-SILODOSIN
Common or Proper name SILODOSIN
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) SILODOSIN
Strength(s) 4MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30's
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-12
Estimated end date 2023-09-30
Actual end date 2023-09-13
Shortage status Resolved
Updated date 2023-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-09-14 English Compare
v10 2023-09-13 French Compare
v9 2023-09-13 English Compare
v8 2023-09-13 French Compare
v7 2023-09-13 English Compare
v6 2023-08-02 French Compare
v5 2023-08-02 English Compare
v4 2023-07-24 French Compare
v3 2023-07-24 English Compare
v2 2022-08-15 French Compare
v1 2022-08-15 English Compare

Showing 1 to 11 of 11